A group of terminally ill patients seeking psilocybin therapy will likely take the Drug Enforcement Administration (DEA) to federal court once again over the agency’s denial to grant access to the treatment under Right To Try (RTT) laws, The Microdose reported.
The Right to Try Act is a 2018 federal law that permits people with life-threatening illnesses to try investigational drugs that have made it past Phase 1 clinical trials. Forty-one states have also enacted Right to Try at the state level.
